HealthEquity (HQY) Projected to Post Earnings on Tuesday

HealthEquity (NASDAQ:HQY - Get Free Report) is anticipated to issue its Q1 2026 quarterly earnings data after the market closes on Tuesday, June 3rd. Analysts expect the company to announce earnings of $0.81 per share and revenue of $322.25 million for the quarter.

HealthEquity Stock Down 0.5%

Shares of HealthEquity stock traded down $0.50 during trading hours on Thursday, hitting $100.98. The company had a trading volume of 780,839 shares, compared to its average volume of 809,757. The company's 50-day moving average is $88.98 and its two-hundred day moving average is $97.45. HealthEquity has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The company has a market cap of $8.73 billion, a P/E ratio of 92.64, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45.

Analyst Ratings Changes

Several research analysts have recently issued reports on HQY shares. Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their target price for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp lowered their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Wells Fargo & Company upped their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a report on Wednesday, February 26th. The Goldman Sachs Group lowered their target price on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Finally, Royal Bank of Canada started coverage on shares of HealthEquity in a report on Thursday, May 22nd. They issued an "outperform" rating and a $112.00 target price for the company. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, HealthEquity presently has an average rating of "Buy" and a consensus target price of $112.33.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. This represents a 6.34% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. The trade was a 13.55% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.